Visual Acuity Outcome Differences Between the Alcon Vivity Toric IOL and RxSight LAL+

Inclusion criteria

• Adult (≥45) subjects who are astigmatic and require bilateral, routine small-incision, surgery for age-related cataracts with femtosecond laser;
• All subjects will be required to be targeted for refractive emmetropia (plano or first minus closest to plano);
• Subjects will have an expected monocular BCDVA outcomes of 20/25 or better in the opinion of the investigator;
• Subjects will have regular corneal astigmatism (1.00 to 2.00 D), which can be corrected with a toric power IOL of T3-T5;
• Subjects will be required to have a dilated pupil diameter of 7 mm or greater in both eyes;

Exclusion criteria

• Moderate-severe corneal pathology;

• Irregular astigmatism;
• Subject desire monovision correction;
• Preexisting macular disease or other retinal degenerative diseases that is expected to cause future vision loss;
• History of glaucoma;
• Severe dry eye disease;
• History of uveitis;
• History of ocular herpes simplex virus;
• History of nystagmus;
• Zonular laxity or dehiscence;
• History psueudoexfoliation;
• History of corneal refractive and intraocular surgery or requiring any other planned ocular surgical procedures;
• Currently taking systemic medication that may increase sensitivity to UV light or that may cause toxicity to the retina;
• Pregnant or breastfeeding.